Anti-Human Trop-2 (Sacituzumab Biosimilar)
Catalog #500055
| Cat # | Size | Price | Quantity | |
|---|---|---|---|---|
| 500055 | 1 mg | $200.00 | ||
| 500055 | 5 mg | $600.00 | ||
| 500055 | 20 mg | $1,250.00 |
Product Details
Sacituzumab biosimilar (Anti-Trop2) is a research-grade monoclonal antibody designed to target Trop2 (TACSTD2), a transmembrane glycoprotein highly expressed in various epithelial cancers. This biosimilar is commonly used in immunoassays such as ELISA, flow cytometry, and immunohistochemistry, and it is also valuable in pharmacokinetics and drug development research. It is a humanized IgG1 antibody that specifically binds to human Trop2.
Specifications
| Clone | Sacituzumab |
|---|---|
| Reactivities | Human |
| Isotype | Human IgG1 |
| Recommended Isotype Control | Human IgG1 isotype control |
| Format | Liquid |
| Formluation | PBS, pH 6.2 |
| Sterility | 0.2 µm filtered |
| Clonality | Recombinant |
| Conjugation | Unconjugated |
| Immunogen | Human Trop-2 |
| Host | CHO cells |
| Purity | >95% (HPLC, SDS-PAGE) |
| Endotoxin | < 1.0 EU/mg (LAL assay) |
| Grade | In vivo ready (RUO) |
| Application | Neutralization; Flow Cytometry; ELISA; WB |
| Purification | Protein A |
| Storage Conditions | 2-8 °C, Avoid freeze / thaw cycle |
| Shelf Life | 6 months |
| Regulatory Status | RUO |